Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

High-dose ICE With Amifostine

NCT00003657

Conditions
AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +80 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

NCT00003200

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Harvard Community Health Plan Boston, Massachusetts, United States
View Trial Details
Completed

Randomized Amifostine For SCCHN

NCT00095927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Chemotherapeutic Agent Toxicity, +18 more
Locations
  • Goodall Hospital Sanford, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord

NCT00002727

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Comprehensive Cancer Institute of Huntsville Huntsville, Alabama, United States
  • Huntsville Hospital System Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
View all 237 locations
View Trial Details
Completed

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

NCT02007200

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +42 more
Locations
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions